Biotech Products
- All
- News
- Videos
-
World's First Saliva Pregnancy Test Launched In UK
The product named Salistick has been developed by an Israeli biotech company and is based on the technology used to make Covid testing kits.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
-
India's Bio-Economy Has Grown 8 Times In Eight Years: PM Modi
PM Modi said today that his government believes in strengthening every sector for giving momentum to the country's development, asserting that it has changed the earlier approach of focusing on a few sectors while ignoring others.
-
Covaxin Production Slowed Down, This Is What Bharat Biotech Will Focus On
Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units.
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
Production, Supply Of Covaxin Time-Taking Process: Bharat Biotech
Amid rising demand for COVID vaccines, Bharat Biotech on Friday said production and supply of Covaxin is a time-consuming process as various procedures and approvals need to be in place before it is made available for vaccination.
-
MK Stalin Urges Centre To Begin Vaccine Production At Its Tamil Nadu Unit
Tamil Nadu Chief Minister MK Stalin on Tuesday urged the Centre to take steps expeditiously to commence production of COVID-19 vaccine, at a facility owned by it near here.
-
Covaxin Has Reached "30 Cities In 30 Days": Bharat Biotech Amid Shortages
New shipments of Bharat Biotech's Covaxin have reached 30 cities in 30 days, the vaccine maker said this morning in a tweet as a shortage of doses continues to be a challenge in India's fight against coronavirus.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Centre Explores Possibility Of Covaxin Production Outside India: Report
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
-
Covaxin Production To Be Scaled Up By Additional 200 Million Doses
Bharat Biotech on Thursday said it's planning to ramp up the manufacturing capacity of its COVID-19 vaccine, Covaxin, by an additional 200 million doses per year.
-
Vaccine Makers Invited To Produce Covaxin To Address Shortage
The central government and Bharat Biotech are willing to invite other companies which want to produce Covaxin to help scale up its production, a top government advisor said on Thursday, as India grapples with a dire shortage of vaccines.
-
Serum Institute, Bharat Biotech To Ramp Up Covid Vaccine Production By August: Report
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively
-
IIT Kanpur, I2Cure Join Hands For Molecular Iodine-Based Products Research
Biotech firm I2Cure on Monday announced a collaboration with the Indian Institute of Technology Kanpur (IIT K) for all future research on molecular iodine-based products.
-
World's First Saliva Pregnancy Test Launched In UK
The product named Salistick has been developed by an Israeli biotech company and is based on the technology used to make Covid testing kits.
-
Uzbekistan Child Deaths: Noida Syrup Manufacturer's Licence Suspended
The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
-
India's Bio-Economy Has Grown 8 Times In Eight Years: PM Modi
PM Modi said today that his government believes in strengthening every sector for giving momentum to the country's development, asserting that it has changed the earlier approach of focusing on a few sectors while ignoring others.
-
Covaxin Production Slowed Down, This Is What Bharat Biotech Will Focus On
Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units.
-
"Quality Issues Behind Covaxin Shortage": Government Vaccine Panel Chief
The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.
-
Production, Supply Of Covaxin Time-Taking Process: Bharat Biotech
Amid rising demand for COVID vaccines, Bharat Biotech on Friday said production and supply of Covaxin is a time-consuming process as various procedures and approvals need to be in place before it is made available for vaccination.
-
MK Stalin Urges Centre To Begin Vaccine Production At Its Tamil Nadu Unit
Tamil Nadu Chief Minister MK Stalin on Tuesday urged the Centre to take steps expeditiously to commence production of COVID-19 vaccine, at a facility owned by it near here.
-
Covaxin Has Reached "30 Cities In 30 Days": Bharat Biotech Amid Shortages
New shipments of Bharat Biotech's Covaxin have reached 30 cities in 30 days, the vaccine maker said this morning in a tweet as a shortage of doses continues to be a challenge in India's fight against coronavirus.
-
Panacea Biotec Soars 5% On Starting Sputnik V Manufacturing in India
"The first batch produced at the company's facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer," Panacea Biotech said
-
Centre Explores Possibility Of Covaxin Production Outside India: Report
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
-
Covaxin Production To Be Scaled Up By Additional 200 Million Doses
Bharat Biotech on Thursday said it's planning to ramp up the manufacturing capacity of its COVID-19 vaccine, Covaxin, by an additional 200 million doses per year.
-
Vaccine Makers Invited To Produce Covaxin To Address Shortage
The central government and Bharat Biotech are willing to invite other companies which want to produce Covaxin to help scale up its production, a top government advisor said on Thursday, as India grapples with a dire shortage of vaccines.
-
Serum Institute, Bharat Biotech To Ramp Up Covid Vaccine Production By August: Report
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively
-
IIT Kanpur, I2Cure Join Hands For Molecular Iodine-Based Products Research
Biotech firm I2Cure on Monday announced a collaboration with the Indian Institute of Technology Kanpur (IIT K) for all future research on molecular iodine-based products.
